Dr. Yubin Kang
Overview
As a physician and scientist, my ultimate goal is to translate research findings from bench to beside to improve patient care. I focus my research and clinical work on treating blood and bone marrow cancers. Most of the patients in my clinic are blood and bone marrow transplant patients and patients with plasma cell diseases such as multiple myeloma, amyloidosis, POEMS syndrome, and Waldenstrom's macroglobulinemia. The research interests in my lab are on the development of new approaches to enhance hematopoietic stem cell engraftment and reconstitution following blood and bone marrow transplant.
Dr. Kang is rated as an Experienced provider by MediFind in the treatment of Primary Amyloidosis. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Schnitzler Syndrome, Bone Marrow Aspiration, and Bone Graft.
His clinical research consists of co-authoring 78 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Primary Amyloidosis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2400 Pratt St, Durham, NC 27705
Additional Areas of Focus
Dr. Kang has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
University Of North Carolina At Chapel Hill
Sascha Tuchman is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Tuchman is rated as an Elite provider by MediFind in the treatment of Primary Amyloidosis. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Tuchman is currently accepting new patients.
Jared Gollob is a Hematologist Oncology provider in Durham, North Carolina. Dr. Gollob is rated as an Advanced provider by MediFind in the treatment of Primary Amyloidosis. His top areas of expertise are Primary Amyloidosis, Familial Transthyretin Amyloidosis, Cardiac Amyloidosis, and Transthyretin Amyloidosis.
University Of North Carolina At Chapel Hill
Samuel Rubinstein is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Rubinstein is rated as a Distinguished provider by MediFind in the treatment of Primary Amyloidosis. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Primary Amyloidosis, and Bone Marrow Aspiration. Dr. Rubinstein is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Multiple MyelomaDr. Kang isElite. Learn about Multiple Myeloma.
- Distinguished
- PlasmacytomaDr. Kang isDistinguished. Learn about Plasmacytoma.
- Relapsed Refractory Multiple Myeloma (RRMM)
- Schnitzler SyndromeDr. Kang isDistinguished. Learn about Schnitzler Syndrome.
- Smoldering Multiple MyelomaDr. Kang isDistinguished. Learn about Smoldering Multiple Myeloma.
- Advanced
- Cardiac AmyloidosisDr. Kang isAdvanced. Learn about Cardiac Amyloidosis.
- Cerebral Amyloid AngiopathyDr. Kang isAdvanced. Learn about Cerebral Amyloid Angiopathy.
- Chronic Graft Versus Host Disease (cGvHD)
- Hereditary Cerebral Amyloid Angiopathy
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Primary Localized Cutaneous Amyloidosis
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Kang isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Bone GraftDr. Kang isExperienced. Learn about Bone Graft.
- Bone Marrow AspirationDr. Kang isExperienced. Learn about Bone Marrow Aspiration.
- Bone Marrow TransplantDr. Kang isExperienced. Learn about Bone Marrow Transplant.